Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Hits QuantWave's Price Target Forecast with Profit of 34.33%

June 06, 2024
On June 6, 2024, ELI LILLY AND COMPANY's stock reached the price target forecast set by QuantWave, leading to a profit of 34.33% for investors who followed the prediction. The forecast signal date was January 9, 2024, when the stock was priced at 619.09 $. The forecast direction indicated a long position, and the target price of 831.6 $ was achieved in less than five months.

This successful forecast for ELI LILLY AND COMPANY highlights the accuracy and reliability of QuantWave's analytics in predicting stock movements. The achievement of the price target showcases the platform's ability to provide valuable insights for investors seeking profitable opportunities in the market.

Several factors may have contributed to ELI LILLY AND COMPANY's stock movement, including positive developments in the company's pipeline, successful product launches, or favorable market conditions within the pharmaceutical sector. QuantWave's sophisticated algorithms and data analytics likely considered these factors when generating the forecast for the stock.

QuantWave is a leading automated forecasting platform that offers users access to predictions for a wide range of stocks, presenting opportunities for potential profits. For investors looking to enhance their understanding of the investment strategy behind QuantWave's forecasts, QuantSchool provides comprehensive educational resources. By delving into QuantSchool's professional investment framework, users can gain insights into the key principles for generating consistent income using the QuantWave forecasting system.

Find out how the ELI LILLY AND COMPANY rate is expected to change

Get Forecast for LLY
There are no comments yet. Be the first to leave a comment
If you want to leave a comment, then you need Login or Register





Other news for LLY

LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....



Related news

REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave Forecast Target with Profit of 15.56%  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecast set by QuantWave on April 4, 2025....

REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 16.89% Profit  ~1 min.

QuantWave's forecast for REGENERON PHARMACEUTICALS, INC. proved accurate as the stock reached the predicted target price on April 4, 2025....

REGNApril 10, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 17.79% Profit: QuantWave's Success  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecast set by QuantWave, resulting in a profit of 17.79%....

REGNApril 8, 2025REGENERON PHARMACEUTICALS, INC. Stock Hits Price Target with 20% Profit: QuantWave Analysis  ~1 min.

In a recent success for QuantWave's forecasting platform, the stock of REGENERON PHARMACEUTICALS, INC. has hit its price target with a 20% profit margin....

LLYJune 7, 2024ELI LILLY AND COMPANY Hits Price Target Forecast with 35.45% Profit, Reflecting QuantWave's Accuracy  ~2 min.

ELI LILLY AND COMPANY, a leading pharmaceutical company, recently achieved the price target forecast set by QuantWave with impressive results....